This expert is a board-certified ophthalmologist and fellowship-trained vitreoretinal specialist with more than 10 years of post-fellowship clinical experience in the medical and surgical management of complex retinal disease. His primary area of expertise is Ophthalmology, with subspecialty focus on disorders of the retina, macula, and vitreous. His clinical practice centers on the evaluation and treatment of age-related macular degeneration, diabetic retinopathy, macular edema, macular holes, epiretinal membranes, retinal vein occlusions, endophthalmitis, macular pucker, lens dislocation and subluxation, retinal detachment, and complications related to cataract surgery.

He completed medical school followed by residency training in ophthalmology and fellowship training in vitreoretinal diseases and surgery. He is board certified by the American Board of Ophthalmology and maintains active medical licensure. His advanced subspecialty training supports his work in vitrectomy, retinal detachment repair, macular hole surgery, surgical management of epiretinal membranes, and treatment of proliferative and non-proliferative retinal vascular disease.

He holds several academic and administrative leadership such as Director roles within a university-affiliated ophthalmology department. His responsibilities include oversight of advanced retinal imaging services, leadership of clinical and translational research initiatives, and direction of a centralized ophthalmic image interpretation program supporting multicenter clinical studies. In these roles, he supervises research operations, contributes to the interpretation and validation of emerging retinal imaging technologies, and provides strategic guidance for investigator-initiated and industry-sponsored clinical trials focused on retinal disease.

He has served as principal investigator and co-investigator on numerous Phases of clinical trials and sponsored research studies evaluating therapies for neovascular and non-neovascular age-related macular degeneration, geographic atrophy, diabetic macular edema, and related retinal disorders. His work includes oversight of regulated clinical research protocols and safety and efficacy studies involving anti-VEGF agents and emerging pharmacologic treatments. He has authored and co-authored peer-reviewed publications addressing retinal surgical techniques, endophthalmitis outcomes, imaging biomarkers, and treatment response in retinal vascular disease, and has delivered invited and peer-reviewed presentations on retinal disease management and surgical innovation.

In addition to his clinical and research leadership, he has served in editorial and manuscript review roles for ophthalmology journals and is an active member and fellow of national professional ophthalmic and surgical organizations. Through his combined clinical, surgical, academic, and research experience, he provides specialized knowledge in the diagnosis, management, and surgical treatment of complex vitreoretinal conditions.